the market. Conversely, in only a few studies, myocardial infarction, heart failure or major adverse cardiac events were not observed with NSAIDs therapy [4] . The unknown long-term effects of these agents in elderly patients are another aspect of NSAIDs therapy that needs to be enlightened. We are not able to comment on this subject since we used flurbiprofen for only 4 weeks in our study [3] . Gastrointestinal adverse effects of flurbiprofen were the most prominent of all and the main reason for resignation from the therapy in our study [3] . However, NSAIDs were found to be well-tolerated at therapeutic doses by a majority of the patients for a short-term period [5] . Again, long-term effects and toxicity of these drugs on the gastrointestinal system need to be further investigated. Adverse effects were not the primary focus of our study, and so we think that large, prospective, long-term and controlled studies are needed to explore the effects of NSAIDs on cardiovascular and gastrointestinal morbidity in the geriatric population. Just like in our study [3] , the NSAIDs therapy resulted in improved symptoms and/or urinary flow associated with BPH [1] . However, as pointed out by Juszczak and Drewa [2] , adverse effects were a major concern restricting the use of NSAIDs for LUTS/BPO treatment. We believe that in the future NSAIDs will find an indication, at least as an adjunct to other conventional drug therapies.
